The aim of the present study is to determine the prevalence of hypercalcemia, hypocalcemia, hypophosphatemia and hyperphosphatemia in newly diagnosed TB patients before and after six-month duration anti-TB treatment in India. Patients were required to attend the treatment facility daily during the first intensive phase (first 8 weeks) of chemotherapy and then 3 times weekly during the continuation phase. These suspected patient Blood samples were collected from seven groups. Blood samples were collected from the subjects of tuberculosis Hospital at Chennai for before treatment and after treatment variations, fasting blood samples were collected from 8 AM - 9 AM. Experiments were carried out as soon as possible. Serum was analyzed for calcium and phosphorus. Phosphorus TB incidence of the patients before treatment and after the end of six-month treatment was found to be low at levels 1.08 to 1.25 mg/dL, medium levels 2.0 to 4.0 mg/dL and high levels 7.5 to 12.84 mg/dL. Calcium TB incidence of the patients for before treatment and after the end of six-month treatment was found to be low at levels 2.0 to 4.0 mg/dL, medium levels 11.0 to 13.0 mg/dL and high levels 7.5 to 12.84 mg/dL. In the present study, mean serum calcium level is much in newly diagnosed patients as compared to after treatment group which became normal after completion of therapy. However, mean serum phosphorous level was much decreased and increased in newly diagnosed patients as compared to the control which came to normal levels after the anti-tubercular therapy. Our findings propose the probability that early intervention will help achieve calcium and phosphorus conversion and ultimately a successful treatment outcome.
